Synthetic Test Data: High-value use cases in medical product development 

Innovation can be a driving force for quality improvement — synthetic data, robust analytics, and AI-powered testing tools can uncover answers at a faster pace than today‘s cumbersome, resource-heavy, disjointed test data management processes. If data were better leveraged, streamlined, and made accessible, medical companies would be able to accelerate innovation and enhance customer experience from high-quality medical products or applications.
Synthetic data is derived from original patient information collected from actual patient populations, provides information about patients’ health statuses and healthcare delivery. Based on data routinely collected from sources such as electronic health records (EHRs), claims and billing activities, and product and disease registries, a completely anonymized, brand new parallel of insights is created. Synthetic data cannot be traced back to individuals in the original patient population like other forms of data (such as de-identified, etc.). Ensuring privacy is crucial to prevent re-identification of individuals or exposure of confidential information. Synthetic data handles the privacy in multiple levels such as data anonymization, data masking, data encryption, differential privacy etc.
Synthetic data in medical imaging offers numerous benefits, including the ability to augment datasets with diverse and realistic images where real data is limited. This reduces the costs and labour associated with annotating real images. Synthetic data also provides an ethical alternative to using sensitive patient data, which helps with education and training without compromising patient privacy.
Synthetic test datasets can be incredibly diverse, encompassing various types of data that reflect different aspects of patient care and medical research. Here are some examples.
These synthetic datasets are designed to maintain the statistical properties and patterns of real data, ensuring they are useful for product development, research and training purposes while protecting patient privacy. For example, a synthetic dataset might include a patient’s journey through a hospital stay, complete with admissions, diagnoses, interventions, and discharge summaries, all fabricated but realistic enough to train machine learning models effectively.
Based on my 20+ years in the trenches for medical devices and healthcare companies, I see that there is an important need to speed up the product development process for medical companies. Complex processes, fragmented data sets, complicated protocols, and long timelines hinder organizations from innovating medical products. The versatility of synthetic patient data makes it a potentially valuable resource for furthering medical product development, while effectively addressing privacy concerns.
Synthetic test data can be incredibly useful in medical product development, but it is important to know where it can and cannot be used effectively. Here are some examples:
Where synthetic test data can be used by medical product companies:
Where synthetic test data should not be used:
Few examples where synthetic test data was utilized by medical product companies:
I see that synthetic data is getting accepted in the medical product development processes and expected to grow in coming years. The key demand drivers are:
The field of synthetic data and AI-powered testing tools is rapidly evolving, with continuous improvements in model accuracy, scalability, and ease of use. Future advancements may include more sophisticated models capable of generating multimodal data, which combines text, images, and numerical data into cohesive synthetic datasets. By leveraging synthetic test data, medical product companies can benefit in enhanced performance/reliability, increased test coverage, and faster time to market.
For further reading, please refer to:
Scroll to Top